Literature DB >> 21696522

Toll-like receptor signaling in liver regeneration, fibrosis and carcinogenesis.

Ekihiro Seki1, Eekjoong Park, Jiro Fujimoto.   

Abstract

Toll-like receptors (TLR) are the germline-coded pattern recognition receptors that sense microbial products. This signaling orchestrates complex signaling pathways that induce expression of inflammatory genes for host defense against invading microorganisms. Recent studies illustrate the role of TLR on non-infectious inflammatory diseases. The liver has a unique anatomy bridging with the intestine by portal vein and bile ducts. This allows delivery of products from intestinal microflora directly into the liver. Subsequently, microbial products cause acute and chronic inflammation through TLR signaling in the liver. Not only exogenous products, but endogenous denatured products released from dying cells also facilitate inflammation even in sterile conditions. Consequently, these responses elicit tissue repairing including liver regeneration and fibrogenesis. An aberrant regenerative response may lead to hepatic carcinogenesis. In this review, we highlight the recently accumulated knowledge about TLR signaling in liver regeneration, fibrosis and carcinogenesis.
© 2011 The Japan Society of Hepatology.

Entities:  

Year:  2011        PMID: 21696522      PMCID: PMC3754784          DOI: 10.1111/j.1872-034X.2011.00822.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  98 in total

1.  Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites.

Authors:  C Guarner; B A Runyon; S Young; M Heck; M Y Sheikh
Journal:  J Hepatol       Date:  1997-06       Impact factor: 25.083

2.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

3.  TLR4 enhances TGF-beta signaling and hepatic fibrosis.

Authors:  Ekihiro Seki; Samuele De Minicis; Christoph H Osterreicher; Johannes Kluwe; Yosuke Osawa; David A Brenner; Robert F Schwabe
Journal:  Nat Med       Date:  2007-10-21       Impact factor: 53.440

4.  TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta.

Authors:  Jonathan C Kagan; Tian Su; Tiffany Horng; Amy Chow; Shizuo Akira; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2008-02-24       Impact factor: 25.606

5.  Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis.

Authors:  Won-Il Jeong; Ogyi Park; Bin Gao
Journal:  Gastroenterology       Date:  2007-09-29       Impact factor: 22.682

6.  Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.

Authors:  Junko Sawaki; Hiroko Tsutsui; Nobuki Hayashi; Koubun Yasuda; Shizuo Akira; Takakuni Tanizawa; Kenji Nakanishi
Journal:  Int Immunol       Date:  2007-02-07       Impact factor: 4.823

7.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

8.  Induction of innate immune response and absence of subsequent tolerance to dsRNA in biliary epithelial cells relate to the pathogenesis of biliary atresia.

Authors:  Kenichi Harada; Yasunori Sato; Kumiko Isse; Hiroko Ikeda; Yasuni Nakanuma
Journal:  Liver Int       Date:  2008-05       Impact factor: 5.828

9.  Current views of toll-like receptor signaling pathways.

Authors:  Masahiro Yamamoto; Kiyoshi Takeda
Journal:  Gastroenterol Res Pract       Date:  2010-12-14       Impact factor: 2.260

10.  Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury.

Authors:  Yumiko Imai; Keiji Kuba; G Greg Neely; Rubina Yaghubian-Malhami; Thomas Perkmann; Geert van Loo; Maria Ermolaeva; Ruud Veldhuizen; Y H Connie Leung; Hongliang Wang; Haolin Liu; Yang Sun; Manolis Pasparakis; Manfred Kopf; Christin Mech; Sina Bavari; J S Malik Peiris; Arthur S Slutsky; Shizuo Akira; Malin Hultqvist; Rikard Holmdahl; John Nicholls; Chengyu Jiang; Christoph J Binder; Josef M Penninger
Journal:  Cell       Date:  2008-04-18       Impact factor: 41.582

View more
  9 in total

1.  Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis.

Authors:  Elizabeth Brandon-Warner; Tracy L Walling; Laura W Schrum; Iain H McKillop
Journal:  Alcohol Clin Exp Res       Date:  2011-10-21       Impact factor: 3.455

Review 2.  Immunological orchestration of liver fibrosis.

Authors:  Hajime Tanaka; Patrick S C Leung; Tom P Kenny; M Eric Gershwin; Christopher L Bowlus
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

3.  TLR3/4 signaling is mediated via the NFκB-CXCR4/7 pathway in human alcoholic hepatitis and non-alcoholic steatohepatitis which formed Mallory-Denk bodies.

Authors:  Hui Liu; Jun Li; Brittany Tillman; Timothy R Morgan; Barbara A French; Samuel W French
Journal:  Exp Mol Pathol       Date:  2014-07-02       Impact factor: 3.362

4.  Activation of natural killer T cells contributes to triptolide-induced liver injury in mice.

Authors:  Xin-Zhi Wang; Ru-Feng Xue; Shen-Ye Zhang; Ya-Ting Zheng; Lu-Yong Zhang; Zhen-Zhou Jiang
Journal:  Acta Pharmacol Sin       Date:  2018-07-16       Impact factor: 6.150

5.  A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse.

Authors:  Anna Moles; Lindsay Murphy; Caroline L Wilson; Jayashree Bagchi Chakraborty; Christopher Fox; Eek Joong Park; Jelena Mann; Fiona Oakley; Rachel Howarth; John Brain; Steven Masson; Michael Karin; Ekihiro Seki; Derek A Mann
Journal:  J Hepatol       Date:  2013-12-11       Impact factor: 25.083

6.  Fagonia indica Repairs Hepatic Damage through Expression Regulation of Toll-Like Receptors in a Liver Injury Model.

Authors:  Fareeha Azam; Nadeem Sheikh; Gibran Ali; Asima Tayyeb
Journal:  J Immunol Res       Date:  2018-07-02       Impact factor: 4.818

7.  Markers of liver regeneration-the role of growth factors and cytokines: a systematic review.

Authors:  Katrin Hoffmann; Alexander Johannes Nagel; Kazukata Tanabe; Juri Fuchs; Karolin Dehlke; Omid Ghamarnejad; Anastasia Lemekhova; Arianeb Mehrabi
Journal:  BMC Surg       Date:  2020-02-12       Impact factor: 2.102

Review 8.  Gut microbiota mediated molecular events and therapy in liver diseases.

Authors:  Xiaoqiang Qi; Ming Yang; Joseph Stenberg; Rahul Dey; Leslie Fogwe; Muhammad Shawkat Alam; Eric T Kimchi; Kevin F Staveley-O'Carroll; Guangfu Li
Journal:  World J Gastroenterol       Date:  2020-12-28       Impact factor: 5.742

Review 9.  The role of the angiotensin II type I receptor blocker telmisartan in the treatment of non-alcoholic fatty liver disease: a brief review.

Authors:  Luciana M A Borém; João F R Neto; Igor V Brandi; Deborah F Lelis; Sergio H S Santos
Journal:  Hypertens Res       Date:  2018-04-10       Impact factor: 3.872

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.